Stay updated on Pediatric Lumateperone Safety Clinical Trial
Sign up to get notified when there's something new on the Pediatric Lumateperone Safety Clinical Trial page.

Latest updates to the Pediatric Lumateperone Safety Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check29 days agoChange DetectedThe page shows a new revision entry 'Revision: v3.3.3' added to the record history, and the footer items 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' are removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check50 days agoChange DetectedA new revision entry 'Revision: v3.3.2' was added to the Record History, and the previous 'Revision: v3.3.1' entry was removed.SummaryDifference0.1%

- Check57 days agoChange DetectedRevision label in the History section updated from v3.2.0 to v3.3.1. No substantive changes to the page content, layout, or study data were observed.SummaryDifference0.1%

- Check65 days agoChange DetectedNew content sections and data have been added to the record history, including Results Posted, Adverse Events, Outcome Measures (Results), Baseline Characteristics, and Participant Flow as of 2025-11-12. The older 'Results Submitted' entry from 2024-08-12 has been removed.SummaryDifference2%

- Check79 days agoChange DetectedThe Record History shows six versions with changes to Study Status, Recruitment Status, Study Design, Contacts/Locations, Outcome Measures, and Submissions; it documents revisions to the trial's status and logistics over time.SummaryDifference0.2%

- Check93 days agoChange DetectedAdds two Results Submission Events and removes one, net increasing the page’s event-tracking entries related to results submissions.SummaryDifference0.3%

Stay in the know with updates to Pediatric Lumateperone Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Lumateperone Safety Clinical Trial page.